Dynamic Advisor Solutions LLC Bristol Myers Squibb CO Transaction History

Dynamic Advisor Solutions LLC

$3.28 Billion
Q3 2024

A detailed history of Dynamic Advisor Solutions LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dynamic Advisor Solutions LLC holds 30,473 shares of BMY stock, worth $1.73 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

30,473

Previous 30,720 0.8%

Holding current value

$1.73 Million

Previous $1.28 Million 23.61%

% of portfolio

0.05%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$39.66 - $51.75 $9,796 - $12,782	-247 Reduced 0.8%	30,473 $1.58 Million
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $145,020 - $190,922	-3,603 Reduced 10.5%	30,720 $1.28 Million
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $72,017 - $81,654	-1,501 Reduced 4.19%	34,323 $1.86 Million
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $54,394 - $64,907	-1,122 Reduced 3.04%	35,824 $1.84 Million
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $225,365 - $251,993	3,893 Added 11.78%	36,946 $2.14 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $35,613 - $39,543	-559 Reduced 1.66%	33,053 $2.11 Million
Q1 2023 Apr 10, 2023	SELL	$65.71 - $74.53 $336,698 - $381,891	-5,124 Reduced 13.23%	33,612 $2.33 Million
Q4 2022 Jan 12, 2023	BUY	$68.48 - $81.09 $709,658 - $840,335	10,363 Added 36.52%	38,736 $0
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $812 - $480,326	6,251 Added 28.26%	28,373 $2.02 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $68,480 - $75,421	943 Added 4.45%	22,122 $1.7 Million
Q1 2022 Apr 11, 2022	BUY	$61.48 - $73.72 $205,097 - $245,929	3,336 Added 18.7%	21,179 $1.55 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $1.19 Million - $1.39 Million	-22,172 Reduced 55.41%	17,843 $1.11 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $116,742 - $136,748	-1,973 Reduced 4.7%	40,015 $2.37 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $109,580 - $119,333	-1,770 Reduced 4.04%	41,988 $2.81 Million
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $1.1 Million - $1.24 Million	18,560 Added 73.66%	43,758 $2.76 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $225,532 - $255,569	3,906 Added 18.34%	25,198 $1.56 Million
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $79,597 - $88,205	1,386 Added 6.96%	21,292 $1.28 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $61,946 - $72,421	1,130 Added 6.02%	19,906 $1.17 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $532,254 - $773,489	-11,471 Reduced 37.92%	18,776 $1.05 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $79,572 - $103,795	1,617 Added 5.65%	30,247 $1.94 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $482,573 - $572,160	-11,283 Reduced 28.27%	28,630 $1.45 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $765,813 - $846,822	17,163 Added 75.44%	39,913 $1.81 Million
Q1 2019 Apr 10, 2019	BUY	$45.12 - $53.8 $10,603 - $12,643	235 Added 1.04%	22,750 $1.09 Million
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $29,158 - $37,811	-598 Reduced 2.59%	22,515 $1.1 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $3,035 - $3,423	-55 Reduced 0.24%	23,113 $1.44 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $137,492 - $171,368	2,721 Added 13.31%	23,168 $1.28 Million
Q1 2018 May 01, 2018	BUY	$59.92 - $68.98 $223,142 - $256,881	3,724 Added 22.27%	20,447 $1.29 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $119 - $130	2 Added 0.01%	16,723 $1.03 Million
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $923,500 - $1.07 Million	16,721	16,721 $1.07 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.

Account

Dynamic Advisor Solutions LLC Bristol Myers Squibb CO Transaction History